J P Morgan Chase & Co set a $136.00 target price on athenahealth, Inc. (NASDAQ:ATHN) in a report released on Wednesday. The firm currently has a hold rating on the health services provider’s stock.
Several other brokerages have also issued reports on ATHN. Oppenheimer Holdings, Inc. restated an outperform rating and set a $154.00 price target (up from $119.00) on shares of athenahealth in a research note on Monday, May 22nd. Barclays PLC set a $88.00 price objective on athenahealth and gave the company an underweight rating in a research note on Monday, May 1st. Jefferies Group LLC reiterated a hold rating and issued a $135.00 price objective on shares of athenahealth in a research note on Monday, June 26th. Stifel Nicolaus reiterated a hold rating and issued a $151.00 price objective (up from $106.00) on shares of athenahealth in a research note on Friday, June 16th. Finally, Evercore ISI reiterated an outperform rating and issued a $147.00 price objective (up from $118.00) on shares of athenahealth in a research note on Friday, May 19th. One equities research analyst has rated the stock with a sell rating, thirteen have assigned a hold rating and twelve have given a buy rating to the company’s stock. The company has a consensus rating of Hold and an average price target of $141.00.
Shares of athenahealth (ATHN) traded up 0.09% during midday trading on Wednesday, reaching $143.51. The company’s stock had a trading volume of 454,272 shares. The stock has a market capitalization of $5.72 billion, a P/E ratio of 282.50 and a beta of 1.79. athenahealth has a 12 month low of $90.11 and a 12 month high of $149.55. The stock’s 50-day moving average is $141.23 and its 200 day moving average is $122.47.
athenahealth (NASDAQ:ATHN) last posted its quarterly earnings data on Thursday, April 27th. The health services provider reported $0.10 EPS for the quarter, missing analysts’ consensus estimates of $0.11 by $0.01. athenahealth had a return on equity of 5.93% and a net margin of 1.84%. The business had revenue of $285.40 million during the quarter, compared to the consensus estimate of $296.49 million. During the same quarter in the previous year, the firm posted $0.34 earnings per share. The company’s revenue for the quarter was up 11.4% on a year-over-year basis. On average, analysts expect that athenahealth will post $1.86 earnings per share for the current fiscal year.
COPYRIGHT VIOLATION NOTICE: This news story was originally reported by StockNewsTimes and is the sole property of of StockNewsTimes. If you are accessing this news story on another domain, it was stolen and republished in violation of US and international trademark & copyright law. The original version of this news story can be accessed at https://stocknewstimes.com/2017/07/20/athenahealth-inc-athn-given-a-136-00-price-target-by-j-p-morgan-chase-co-analysts.html.
In other athenahealth news, CEO Jonathan Bush sold 4,000 shares of the stock in a transaction dated Monday, July 3rd. The stock was sold at an average price of $140.52, for a total transaction of $562,080.00. Following the completion of the transaction, the chief executive officer now owns 319,807 shares in the company, valued at approximately $44,939,279.64. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, SVP Jonathan D. Porter sold 300 shares of the stock in a transaction dated Monday, July 17th. The stock was sold at an average price of $143.13, for a total value of $42,939.00. The disclosure for this sale can be found here. In the last quarter, insiders have sold 25,683 shares of company stock valued at $3,329,871. Corporate insiders own 3.20% of the company’s stock.
Several institutional investors have recently bought and sold shares of ATHN. BlackRock Inc. increased its position in athenahealth by 30,642.6% in the first quarter. BlackRock Inc. now owns 1,599,847 shares of the health services provider’s stock worth $180,286,000 after buying an additional 1,594,643 shares in the last quarter. Morgan Stanley increased its position in athenahealth by 9.7% in the first quarter. Morgan Stanley now owns 4,514,305 shares of the health services provider’s stock worth $508,717,000 after buying an additional 397,837 shares in the last quarter. Clearbridge Investments LLC increased its position in athenahealth by 61.8% in the first quarter. Clearbridge Investments LLC now owns 908,505 shares of the health services provider’s stock worth $102,379,000 after buying an additional 347,133 shares in the last quarter. Credit Suisse AG increased its position in athenahealth by 404.5% in the first quarter. Credit Suisse AG now owns 300,420 shares of the health services provider’s stock worth $33,854,000 after buying an additional 240,876 shares in the last quarter. Finally, Norges Bank acquired a new position in athenahealth during the fourth quarter worth approximately $20,750,000.
About athenahealth
athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.
Receive News & Ratings for athenahealth Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc. and related companies with MarketBeat.com's FREE daily email newsletter.
